Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF). 1992

R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
Department of Haematology, Philipps-Universität, Marburg, Germany.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D016179 Granulocyte Colony-Stimulating Factor A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines. Colony-Stimulating Factor, Granulocyte,G-CSF,Myeloid Growth Factor,Colony Stimulating Factor, Granulocyte,Factor, Granulocyte Colony-Stimulating,Factor, Myeloid Growth,Granulocyte Colony Stimulating Factor,Growth Factor, Myeloid

Related Publications

R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
March 1994, Psychiatrische Praxis,
R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
August 1994, Journal of clinical psychopharmacology,
R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
January 1996, Psychopharmacology bulletin,
R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
November 1996, The American journal of psychiatry,
R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
February 1994, Polskie Archiwum Medycyny Wewnetrznej,
R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
November 1993, Journal of internal medicine,
R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
September 1994, The Journal of clinical psychiatry,
R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
October 1994, Deutsche medizinische Wochenschrift (1946),
R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
May 1993, Annals of hematology,
R Weide, and H Köppler, and J Heymanns, and K H Pflüger, and K Havemann
October 1992, Lancet (London, England),
Copied contents to your clipboard!